Treating Tobacco Smoking After the Diagnosis of Lung Cancer: It's Not Too Late and a Call to Action
Menée en Russie entre 2007 et 2016 auprès de 517 fumeurs atteints d'un cancer du poumon (durée de suivi : 7 ans), cette étude analyse l'effet, sur la progression et la survie, du sevrage tabagique après le diagnostic de la maladie
Lung cancer is the leading cause of cancer death in the United States, expected to claim nearly 132 000 lives in 2021 despite recent treatment advances that have accelerated a decline in lung cancer mortality rates (1). Only 21% of patients with lung cancer survive 5 years, primarily because 57% of lung cancer is metastatic at the time of diagnosis (1). Lung cancer screening with low-dose computed tomography has the potential to improve survival rates by shifting cancer diagnoses to earlier disease stages. Even so, the prognosis of localized lung cancer remains poor, with a 5-year survival rate of 59%.